IGF-1 Novel peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090038022A1
SERIAL NO

11791722

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel polypeptide constructs based on peptides derived from Insulin-like Growth Factor I (IGF-1). The invention also relates to novel uses for IGF-1-derived peptides, particularly for the prevention and treatment of diseases involving regulation of cellular growth or differentiation, regeneration and tissue repair.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EUROPEAN MOLECULAR BIOLOGY LABORATORYMEYERHOFSTRASSE 1 69117 HEIDELBERG GERMANY
ROME UNIVERSITY OFLA SAPIENZA I-00161 ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Musaro, Antonio Rome, IT 2 7
Rosenthal, Nadia Heidelberg, DE 5 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation